Insights
Cipla Shares Fall on USFDA Compliance Observations at Key Partner Facility
Jan 8
NSE · Pharma
CiplaCIPLA
Nifty 50
Cipla (CIPLA) is an NSE-listed company. This page brings together its recent bulk & block deals, AI-scored exchange filings and corporate actions.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 13 Per Share
ex 2026-06-05
Filings that matter
- 1ESG / BRSRNeutral
Cipla Limited submitted its latest Business Responsibility and Sustainability Report. Impact: 1/10 · Neutral
- 1GeneralNeutral
The AGM notice for Cipla Limited has a corrected date for remote e-voting. - This change does not alter the overall content of the AGM notice. Impact: 1/10 · Neutral
Source PDF → - 1ESG / BRSRNeutral
Submission of annual ESG/BRSR report. • No specific financial impacts mentioned. Impact: 1/10 · Neutral
- 1ESG / BRSRNeutral
Submission of ESG/BRSR report. • No specific financial impacts mentioned. Impact: 1/10 · Neutral
- 1ESG / BRSRNeutral
Cipla Limited submitted its latest Business Responsibility and Sustainability Report. Impact: 1/10 · Neutral
- 1GeneralNeutral
Cipla Limited allotted 44,770 fully paid-up equity shares. - This increase in share capital is due to the exercise of employee stock options and stock appreciation rights. Impact: 1/10 · Neutral
Source PDF → - 2GeneralNeutral
Allotment of securities announced. - Fund raising through capital alteration. Impact: 2/10 · Neutral
Bulk & block deals
No recent bulk/block deals for CIPLA.
Results & transcripts
Financial results
- Cipla Limited
- Cipla Limited
- Cipla Limited
- Cipla Limited
Calls & transcripts
None yet.